144 related articles for article (PubMed ID: 31759158)
1. Reliability and Validity of the Modified 7-Day Lee Chronic Graft-versus-Host Disease Symptom Scale.
Teh C; Onstad L; Lee SJ
Biol Blood Marrow Transplant; 2020 Mar; 26(3):562-567. PubMed ID: 31759158
[TBL] [Abstract][Full Text] [Related]
2. Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.
Merkel EC; Mitchell SA; Lee SJ
Biol Blood Marrow Transplant; 2016 Apr; 22(4):752-758. PubMed ID: 26751003
[TBL] [Abstract][Full Text] [Related]
3. Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population.
Vasconcellos de Souza C; Vigorito AC; Miranda ECM; Garcia C; Rensi Colturato VA; Mauad MA; Rodrigues Moreira MC; da Silva Bouzas LF; Lermontov S; Hamerschlak N; Rodrigues M; Carlos de Almeida Barros J; Chiattone R; Lee SJ; Flowers MED
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1313-1318. PubMed ID: 27058616
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.
Lee Sk; Cook EF; Soiffer R; Antin JH
Biol Blood Marrow Transplant; 2002; 8(8):444-52. PubMed ID: 12234170
[TBL] [Abstract][Full Text] [Related]
5. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
[TBL] [Abstract][Full Text] [Related]
6. Development and psychometric testing of a pediatric chronic graft-versus-host disease symptom scale: protocol for a two-phase, mixed methods study.
Mitchell SA; Hunter R; Fry A; Pavletic SZ; Widemann BC; Wiener L
Front Psychol; 2023; 14():1243005. PubMed ID: 38259542
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported outcomes and health status associated with chronic graft-
Lee SJ; Onstad L; Chow EJ; Shaw BE; Jim HSL; Syrjala KL; Baker KS; Buckley S; Flowers ME
Haematologica; 2018 Sep; 103(9):1535-1541. PubMed ID: 29858386
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review of Patient-Reported Outcome Measures in Graft-versus-Host Disease.
Kilgour JM; Wali G; Gibbons E; Scherwath A; Barata Badiella A; Peniket A; Schoemans H; Matin RN;
Biol Blood Marrow Transplant; 2020 May; 26(5):e113-e127. PubMed ID: 32028026
[TBL] [Abstract][Full Text] [Related]
9. Symptoms, Cytokines, and Quality of Life in Patients Diagnosed with Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
Lynch Kelly D; Lyon DE; Ameringer SA; Elswick RK
Oncol Nurs Forum; 2015 May; 42(3):265-75. PubMed ID: 25901378
[TBL] [Abstract][Full Text] [Related]
10. Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus.
Lutz M; Kapp M; Einsele H; Grigoleit GU; Mielke S
Clin Transplant; 2014 Dec; 28(12):1410-5. PubMed ID: 25287756
[TBL] [Abstract][Full Text] [Related]
11. Oral Complications of Chronic Graft-Versus-Host Disease.
Fall-Dickson JM; Pavletic SZ; Mays JW; Schubert MM
J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425593
[TBL] [Abstract][Full Text] [Related]
12. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
[TBL] [Abstract][Full Text] [Related]
13. Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylate.
Rosenthal EA; Ho PS; Joe GO; Mitchell SA; Booher S; Pavletic SZ; Baird K; Cowen EW; Comis LE
Support Care Cancer; 2020 Aug; 28(8):3679-3689. PubMed ID: 31811481
[TBL] [Abstract][Full Text] [Related]
14. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported symptom burden of chronic graft versus host disease: a systematic literature review.
Csanádi M; Ágh T; Farkas-Ráduly S; Gros B; Tapprich C; Trudeau JJ; Lipton JH; Mattsson J
Expert Rev Hematol; 2020 Oct; 13(10):1119-1130. PubMed ID: 32865071
[TBL] [Abstract][Full Text] [Related]
16. Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice.
Curtis LM; Datiles MB; Steinberg SM; Mitchell SA; Bishop RJ; Cowen EW; Mays J; McCarty JM; Kuzmina Z; Pirsl F; Fowler DH; Gress RE; Pavletic SZ
Haematologica; 2015 Sep; 100(9):1228-36. PubMed ID: 26088932
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD.
Dietrich-Ntoukas T; Cursiefen C; Westekemper H; Eberwein P; Reinhard T; Bertz H; Nepp J; Lawitschka A; Heiligenhaus A; Seitz B; Messmer EM; Meyer-ter-Vehn T; Basara N; Greinix H; Datiles MB; Lee SJ; Pavletic SZ; Wolff D
Cornea; 2012 Mar; 31(3):299-310. PubMed ID: 22157574
[TBL] [Abstract][Full Text] [Related]
18. The benefit of chronic graft-versus-host disease in patients with acute myeloid leukemia relapsed after allogeneic stem cell transplantation.
Wang Z; Yin C; Zhang W; Tang W; Song X; Hu X; Ni X; Qiu H; Yang J; Hu J; Wang J
Ann Hematol; 2019 Jul; 98(7):1765-1773. PubMed ID: 30993416
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
20. Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.
Partanen J; Hyvärinen K; Bickeböller H; Bogunia-Kubik K; Crossland RE; Ivanova M; Perutelli F; Dressel R
Front Immunol; 2020; 11():575492. PubMed ID: 33193367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
